Recurrent Mitral Regurgitation After Repair: Four Years Later, Moderate Again
A durable-looking mitral repair has quietly slipped back to moderate regurgitation in a patient who feels nothing at all. The disagreement is about whether to act on a finding this early or wait for it to declare itself further.
D.K., a 58-year-old woman, has spent the four years since her mitral valve repair mostly forgetting she ever needed one — she walks three miles most mornings before the substitute-teaching shifts she picked up to stay busy in retirement, and the only real deadline on her mind lately is her grandson's wedding in eight months, where she has already told her daughter she intends to dance. Her surgeon repaired a prolapsing posterior leaflet with an annuloplasty ring at fifty-four, after routine imaging caught myxomatous degeneration before it caused her any symptoms at all; the regurgitation that had prompted the operation dropped to trace, then mild, and stayed there through three years of yearly echocardiograms that were, each time, unremarkable enough to barely discuss.
This year's echo was different. The regurgitation has climbed back to moderate, and a small area near the repair site now shows abnormal leaflet motion — not the wide, clearly failed repair that would make this an easy call, but a specific, localized finding consistent with either early partial ring dehiscence or a new segment of prolapse developing adjacent to the original one. Her left ventricle has drifted slightly larger on serial imaging, still within the range most echo labs call normal, but moving in a direction that wasn't true a year ago. She has no symptoms whatsoever — no dyspnea on her morning walks, no palpitations, nothing she'd bring up unprompted — and that absence is precisely what makes the finding hard to act on and hard to ignore in equal measure. Repairs that begin failing don't always fail on a predictable timeline, and moderate regurgitation caught early, while she still feels nothing, is a different kind of data than moderate regurgitation discovered because she finally noticed something.
Reviewing a surveillance echo four years after repair
Recurrent regurgitation after a mitral repair tends to progress rather than plateau, and reoperating early — while she's still asymptomatic and her ventricle is still near-normal — is a technically easier field than waiting for severe regurgitation or ventricular decline to force the issue. The finding is also specific and localized, which makes a durable re-repair genuinely plausible right now. Wait long enough and that same anatomy can become one that only replacement, not repair, can fix.
Moderate regurgitation, asymptomatic, with preserved ejection fraction, sits squarely within guideline territory for continued surveillance, not intervention — severe regurgitation, or symptoms, or the ventricle crossing the defined thresholds — ejection fraction at or below 60 percent, end-systolic diameter at or above 40 millimeters — is what triggers reoperation, not a moderate finding on its own. I'll grant that her 60 percent sits right on that line, which in a regurgitant ventricle running supranormal is worth watching rather than filing as reassuring; it just isn't an indication at moderate severity. Redo mitral surgery carries meaningfully higher risk than a first-time operation given the scar tissue involved, and moving on a moderate, asymptomatic finding risks intervening a full stage earlier than the evidence supports.
I'd rather tighten her surveillance interval and watch the actual trajectory than commit her to a harder operation before we know whether this is progressing or simply where her repair naturally settled.
Worth being precise about what medical therapy can and can't do here in the meantime. Afterload reduction has a real, trial-backed rationale in secondary mitral regurgitation, where a dilated ventricle is pulling the valve open — that's not her situation. Hers is primary, degenerative disease, where lowering systemic vascular resistance may modestly reduce the regurgitant fraction but isn't expected to meaningfully change the mechanical problem at the repair site. I'd optimize her lisinopril dose for its own sake, but nobody should mistake that for a substitute for deciding the actual surveillance-versus-reoperation question, which rests on her echo trajectory, not on a medication.
Agreed: repeat echocardiogram in six months rather than waiting the usual full year, lisinopril dose reviewed and optimized, no restriction on her current activity.
Not agreed, and the reason the shortened interval carries real consequences rather than being a formality:
Earlier reoperation is favored while durable re-repair, rather than replacement, is still likely feasible.
Return to annual surveillance, treating this year's finding as within the natural variability long-term repairs can show.
The surgeon and the cardiologist left with genuinely different priors about how likely this particular finding is to keep progressing — a disagreement the shortened interval is designed to narrow with real data rather than settle by argument alone.